ABOS vs WELL · $73.3M cap vs P/E 100, rev $10.84B
Acumen Pharmaceuticals Inc (ABOS) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
ABOS does not have a complete income-statement cache yet.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ABOS currently screens at market cap $73.3M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ABOS and WELL stock pages for the full models.
Not investment advice.